Lauren Merendino

CIK 1855298 · Chief Commercial Officer · last filed 2026-04-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

15

Lifetime Open-Market Net

-$343.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Day One Biopharmaceuticals, Inc. (DAWN) Delisted Chief Commercial Officer 0 $21.53 $0 -$150.7K 7 2026-04-23
ESSA Pharma Inc. (EPIX) Delisted Director $0.20 $0 1 2024-03-28
Myovant Sciences Ltd. (MYOV) Delisted Chief Commercial Officer 147,747 $26.98 $3.99M -$192.5K 7 2023-03-10

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-10-20 Myovant Sciences Ltd. (MYOV) Delisted Sell (S) −1,703 -$42.9K EDGAR
2022-07-20 Myovant Sciences Ltd. (MYOV) Delisted Sell (S) −1,704 -$21.9K EDGAR
2022-04-21 Myovant Sciences Ltd. (MYOV) Delisted Sell (S) −7,049 -$73.7K EDGAR
2022-04-19 Myovant Sciences Ltd. (MYOV) Delisted Grant (A) +103,703 $0 EDGAR
2021-04-19 Myovant Sciences Ltd. (MYOV) Delisted Grant (A) +78,299 $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.